ABBVIE, INC. for ABBVIE INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S.1040, Drug Competition Enhancement Act Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| RACHEL DERBY | — |
| GAVIN PROFFITT New | Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Health Issues HCR
S. 864, HELP Copays Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act S. 2903, Safe Step Act H.R. 5509, Safe Step Act Drug cost and pricing policy issues Patient affordability issues Issues related to the 340B program Issues related to data privacy Issues related to Hepatitis C elimination Issues related to FDA communications
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| RACHEL DERBY | — |
| GAVIN PROFFITT New | Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Medicare/Medicaid MMM
Public Law 117-169 (formerly known as H.R. 5376, Inflation Reduction Act) Implementation regarding Medicare Part D drug negotiation program Policy Proposals related to Medicare Part D and patient cost-sharing Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues Issues related to HCV treatment
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| RACHEL DERBY | — |
| GAVIN PROFFITT New | Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Taxation/Internal Revenue Code TAX
H.R. 1328, Supply Chain Security and Growth Act of 2025 H.R. 1990, American Innovation and R&D Competitiveness Act of 2025 Public Law No: 119-21 (formerly known as H.R. 1, One Big Beautiful Bill Act) Implementation Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation Policy proposals relating to economic activity in Puerto Rico International tax issues, including OECD digital taxation work program
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| RACHEL DERBY | — |
| GAVIN PROFFITT New | Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Labor Issues/Antitrust/Workplace LBR
Issues related to antitrust and competition policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| RACHEL DERBY | — |
| GAVIN PROFFITT New | Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Trade (domestic/foreign) TRD
Issues related to pharmaceutic tariffs and unfair trade practices Issues related to U.S. biotech competitiveness with China
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| RACHEL DERBY | — |
| GAVIN PROFFITT New | Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.